Interpace Biosciences, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2024
Total Assets: $14.8M
Liabilities Breakdown FY2024
Total Liabilities: $17.0M
Asset Breakdown
Total Assets: $14.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.5M | 9.9% |
| Accounts Receivable | $8.5M | 57.8% |
| Inventory | $1.2M | 8.2% |
| Property, Plant & Equipment | $1.4M | 9.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $2.2M | 15.0% |
Liabilities Breakdown
Total Liabilities: $17.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.7M | 9.8% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $15.4M | 90.2% |